Przedsiębiorstwo Farmaceutyczne LEK-AM Sp. o.o. is one of the most dynamically developing pharmaceutical companies on the Polish market.
At present the company employs over 440 people and this number is gradually growing together with an expansion of individual company’s divisions.
Methods of manufacturing meet all requirements of Good Manufacturing Practice (GMP) and products for clinical studies are manufactured in accordance with the guidelines of Good Laboratory Practice (GLP) and GMP
One of the most important objectives of LEK-AM's activity is continuous development and providing patients with modern generic drugs at a reasonable price. The company has been conducting research in the field of drug form technology and pharmaceutical analytics since its inception. In recent years, the Research and Development Department has undergone a significant reorganization, which involved moving the entire department to modern premises, increasing the number of highly qualified specialists, and investing in the latest generation of analytical and technological equipment.